These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15024191)

  • 21. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
    Schallreuter KU; Salem MA; Holtz S; Panske A
    FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic Analysis of Stable and Unstable Vitiligo: A Study of 66 Cases.
    Yadav AK; Singh P; Khunger N
    Am J Dermatopathol; 2016 Aug; 38(8):608-13. PubMed ID: 26978003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo.
    Moellmann G; Klein-Angerer S; Scollay DA; Nordlund JJ; Lerner AB
    J Invest Dermatol; 1982 Nov; 79(5):321-30. PubMed ID: 7130745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hair follicles in the repigmentation of vitiligo.
    Cui J; Shen LY; Wang GC
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study.
    Attwa E; Gamil H; Assaf M; Ghonemy S
    Arch Dermatol Res; 2012 Dec; 304(10):823-30. PubMed ID: 22832941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathology of vitiliginous skin.
    Gokhale BB; Mehta LN
    Int J Dermatol; 1983 Oct; 22(8):477-80. PubMed ID: 6642834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis.
    Lee AY; Youm YH; Kim NH; Yang H; Choi WI
    Br J Dermatol; 2004 Nov; 151(5):995-1003. PubMed ID: 15541077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal histological findings in active vitiligo include the normal-appearing skin.
    Pretti Aslanian FM; Noé RA; Cuzzi T; Filgueira AL
    Pigment Cell Res; 2007 Apr; 20(2):144-5. PubMed ID: 17371442
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased anthralin irritation response in vitiliginous skin.
    Westerhof W; Buehre Y; Pavel S; Bos JD; Das PK; Krieg SR; Siddiqui AH
    Arch Dermatol Res; 1989; 281(1):52-6. PubMed ID: 2730143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical markers of vitiligo activity.
    Benzekri L; Gauthier Y
    J Am Acad Dermatol; 2017 May; 76(5):856-862. PubMed ID: 28245942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural study of vitiligo.
    Galadari E; Mehregan AH; Hashimoto K
    Int J Dermatol; 1993 Apr; 32(4):269-71. PubMed ID: 8486458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural studies in stable vitiligo.
    Panuncio AL; Vignale R
    Am J Dermatopathol; 2003 Feb; 25(1):16-20. PubMed ID: 12544094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
    Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Dutrieux RP; Das PK
    J Invest Dermatol; 1993 Jun; 100(6):816-22. PubMed ID: 7684427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vitiligo occurring on dermal melanocytosis (nevus of Ota) in a dark-skinned patient].
    Ahogo KC; Gbery IP; Vagamon B; Ouattara OA; Kouassi KA; Kourouma HS; Kouassi YI
    Ann Dermatol Venereol; 2017 Nov; 144(11):712-714. PubMed ID: 28728861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatoscopy of blue vitiligo.
    Chandrashekar L
    Clin Exp Dermatol; 2009 Jul; 34(5):e125-6. PubMed ID: 19438538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatitis herpetiformis and vitiligo: report of a case and review of the literature.
    Amato L; Gallerani I; Fuligni A; Mei S; Fabbri P
    J Dermatol; 2000 Jul; 27(7):462-6. PubMed ID: 10935345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.